Insider · CIK 0001280154

Ocampo Christine

CIK 0001280154 Name as filed on the most recent filing

Filed as Ocampo Christine (19)

31 transaction lines · from 19 filings · filed 2005-05-19 to 2017-05-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

31 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-05-10 P, Open-market purchase Novus Therapeutics, Inc.NVUS 100,000, acquired Open Form 4 filing 0000899243-17-012930
2014-12-18 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 97,855, disposed Open Form 4 filing 0001209191-14-076841
2014-12-16 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2 lines 508,200, disposed Open Form 4 filing 0001209191-14-076841
2014-10-24 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 24,565, disposed Open Form 4 filing 0001209191-14-064836
2014-09-15 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 519,750, disposed Open Form 4 filing 0001209191-14-058496
2014-08-26 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 12,871, disposed Open Form 4 filing 0001209191-14-054896
2014-05-16 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 58,072, disposed Open Form 4 filing 0001209191-14-034817
2014-05-14 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 131,307, disposed Open Form 4 filing 0001209191-14-034817
2013-12-18 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 6,445, disposed Open Form 4 filing 0001209191-13-058259
2013-05-15 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2 lines 255,250, disposed Open Form 4 filing 0001209191-13-027420
2012-12-03 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 7,258, disposed Open Form 4 filing 0001209191-12-055927
2012-09-17 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 226,824, disposed Open Form 4 filing 0001209191-12-046187
2012-03-06 P, Open-market purchase Avanir Pharmaceuticals, Inc.AVNR 7,795, acquired Open Form 4 filing 0001209191-12-016317
2011-12-02 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 6,372, disposed Open Form 4 filing 0001209191-11-059752
2011-11-11 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 242,055, disposed Open Form 4 filing 0001209191-11-055813
2010-12-06 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 51,771, disposed Open Form 4 filing 0001209191-10-059051
2010-12-03 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2 lines 94,101, disposed Open Form 4 filing 0001209191-10-058460
2010-12-02 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 99,600, disposed Open Form 4 filing 0001209191-10-058460
2010-08-11 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2 lines 87,732, disposed Open Form 4 filing 0001209191-10-042615
2010-03-16 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 4 lines 32,283, disposed Open Form 4 filing 0001209191-10-017673
2009-02-24 P, Open-market purchase Avanir PharmaceuticalsAVNR 2 lines 5,216, acquired Open Form 4 filing 0001209191-09-011519
2005-05-19 P, Open-market purchase Cardiogenesis Corp /CACGCP 2 lines 8,700, acquired Open Form 4 filing 0001209191-05-027085

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. OCAMPO CHRISTINE, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001280154

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.